Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Palbociclib improves progression-free survival in HR-positive, HER2-positive metastatic breast cancer
The addition of the CDK4/6 inhibitor palbociclib to standard maintenance therapy significantly improved progression-free survival…
Chrono-oncology: Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
A randomised phase III trial published in Nature Medicine has reported an association between the…
App-based biometric coaching associated with improved clinician well-being and reduced burnout
Burnout among health care professionals has become a persistent and pressing issue, especially in high-stress…
Air pollution linked with worse cardiac remodelling and function in breast cancer patients receiving cardiotoxic therapy
- Breast cancer risk markers linked to physical activity in adolescent girls
- PBS listing announced for treatment of unresectable or metastatic, well-differentiated extra-pancreatic or pancreatic neuroendocrine tumours
- NCCN Guidelines acknowledge MammaPrint for guiding anthracycline use in early-stage breast cancer
Genetics Masterclass with Dr Hilda High: Part 1
Join us as we dive into the complex and fascinating world of cancer genetics. Our Host Rachael Babin is joined…
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma
- ESMO 2025: Thymic health linked to immunotherapy response
- ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC
- ASTRO 2025: Pulsed low dose rate chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with oesophageal cancer and non-small cell lung cancer
Further MRI reform required for fair access says RANZCR
Further reform to how Australians access MRI scans is required to ensure fair and equitable access to treatment, says the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.